Flynn James E 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:10 am Unchanged |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 4.960% |
0 (Unchanged) |
Filing |
| 2022-05-11 1:50 pm Purchase |
2022-05-10 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 5.040% |
1,324,214 (New Position) |
Filing |